| UniProt ID | CALU_HUMAN | |
|---|---|---|
| UniProt AC | O43852 | |
| Protein Name | Calumenin | |
| Gene Name | CALU | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 315 | |
| Subcellular Localization | Endoplasmic reticulum membrane . Golgi apparatus . Secreted . Melanosome . Sarcoplasmic reticulum lumen . Identified by mass spectrometry in melanosome fractions from stage I to stage IV. | |
| Protein Description | Involved in regulation of vitamin K-dependent carboxylation of multiple N-terminal glutamate residues. Seems to inhibit gamma-carboxylase GGCX. Binds 7 calcium ions with a low affinity (By similarity).. | |
| Protein Sequence | MDLRQFLMCLSLCTAFALSKPTEKKDRVHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAKTFDQLTPEESKERLGKIVSKIDGDKDGFVTVDELKDWIKFAQKRWIYEDVERQWKGHDLNEDGLVSWEEYKNATYGYVLDDPDPDDGFNYKQMMVRDERRFKMADKDGDLIATKEEFTAFLHPEEYDYMKDIVVQETMEDIDKNADGFIDLEEYIGDMYSHDGNTDEPEWVKTEREQFVEFRDKNRDGKMDKEETKDWILPSDYDHAEAEARHLVYESDQNKDGKLTKEEIVDKYDLFVGSQATDFGEALVRHDEF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 (in isoform 14) | Phosphorylation | - | 22.42 | 24043423 | |
| 4 (in isoform 3) | Phosphorylation | - | 22.42 | 24043423 | |
| 4 (in isoform 4) | Phosphorylation | - | 22.42 | 24043423 | |
| 19 (in isoform 14) | Phosphorylation | - | 32.91 | 24043423 | |
| 19 (in isoform 3) | Phosphorylation | - | 32.91 | 24043423 | |
| 19 (in isoform 4) | Phosphorylation | - | 32.91 | 24043423 | |
| 22 (in isoform 14) | Phosphorylation | - | 65.26 | 24043423 | |
| 22 (in isoform 3) | Phosphorylation | - | 65.26 | 24043423 | |
| 22 (in isoform 4) | Phosphorylation | - | 65.26 | 24043423 | |
| 27 (in isoform 14) | Phosphorylation | - | 38.25 | 24043423 | |
| 27 (in isoform 3) | Phosphorylation | - | 38.25 | 24043423 | |
| 27 (in isoform 4) | Phosphorylation | - | 38.25 | 24043423 | |
| 35 | Phosphorylation | VHHEPQLSDKVHNDA CCCCCCHHHHHCCCH | 30.09 | 23927012 | |
| 35 | O-linked_Glycosylation | VHHEPQLSDKVHNDA CCCCCCHHHHHCCCH | 30.09 | OGP | |
| 37 | Ubiquitination | HEPQLSDKVHNDAQS CCCCHHHHHCCCHHH | 41.85 | - | |
| 44 | Phosphorylation | KVHNDAQSFDYDHDA HHCCCHHHCCCCCHH | 23.08 | 20201521 | |
| 47 | Phosphorylation | NDAQSFDYDHDAFLG CCHHHCCCCCHHCCC | 17.11 | 28355574 | |
| 59 | Ubiquitination | FLGAEEAKTFDQLTP CCCHHHHCCHHHCCH | 53.67 | - | |
| 60 | Phosphorylation | LGAEEAKTFDQLTPE CCHHHHCCHHHCCHH | 39.22 | 25159151 | |
| 60 | O-linked_Glycosylation | LGAEEAKTFDQLTPE CCHHHHCCHHHCCHH | 39.22 | 51377199 | |
| 60 (in isoform 2) | Phosphorylation | - | 39.22 | 25159151 | |
| 60 (in isoform 7) | Phosphorylation | - | 39.22 | 25159151 | |
| 60 (in isoform 8) | Phosphorylation | - | 39.22 | 25159151 | |
| 65 | Phosphorylation | AKTFDQLTPEESKER HCCHHHCCHHHHHHH | 24.03 | 25159151 | |
| 65 (in isoform 2) | Phosphorylation | - | 24.03 | 25159151 | |
| 65 (in isoform 7) | Phosphorylation | - | 24.03 | 25159151 | |
| 65 (in isoform 8) | Phosphorylation | - | 24.03 | 25159151 | |
| 68 (in isoform 4) | Phosphorylation | - | 69.21 | 25159151 | |
| 69 | Phosphorylation | DQLTPEESKERLGKI HHCCHHHHHHHHHHH | 37.85 | 28355574 | |
| 69 (in isoform 2) | Phosphorylation | - | 37.85 | 25849741 | |
| 69 (in isoform 7) | Phosphorylation | - | 37.85 | 25849741 | |
| 69 (in isoform 8) | Phosphorylation | - | 37.85 | 25849741 | |
| 70 | Sumoylation | QLTPEESKERLGKIV HCCHHHHHHHHHHHH | 50.57 | - | |
| 70 | Ubiquitination | QLTPEESKERLGKIV HCCHHHHHHHHHHHH | 50.57 | 21906983 | |
| 70 | Sumoylation | QLTPEESKERLGKIV HCCHHHHHHHHHHHH | 50.57 | - | |
| 70 (in isoform 2) | Ubiquitination | - | 50.57 | 21890473 | |
| 73 (in isoform 15) | Phosphorylation | - | 9.57 | - | |
| 73 (in isoform 4) | Phosphorylation | - | 9.57 | 25159151 | |
| 75 | Ubiquitination | ESKERLGKIVSKIDG HHHHHHHHHHHHHCC | 44.52 | - | |
| 77 (in isoform 4) | Phosphorylation | - | 5.63 | 25849741 | |
| 78 (in isoform 1) | Ubiquitination | - | 27.63 | 21890473 | |
| 79 | Ubiquitination | RLGKIVSKIDGDKDG HHHHHHHHHCCCCCC | 33.64 | - | |
| 79 | Acetylation | RLGKIVSKIDGDKDG HHHHHHHHHCCCCCC | 33.64 | 27452117 | |
| 84 | Ubiquitination | VSKIDGDKDGFVTVD HHHHCCCCCCCEEHH | 66.34 | 21890473 | |
| 89 | Phosphorylation | GDKDGFVTVDELKDW CCCCCCEEHHHHHHH | 21.70 | - | |
| 92 | Ubiquitination | DGFVTVDELKDWIKF CCCEEHHHHHHHHHH | 54.07 | 21890473 | |
| 94 | Ubiquitination | FVTVDELKDWIKFAQ CEEHHHHHHHHHHHH | 49.31 | 21890473 | |
| 94 (in isoform 2) | Ubiquitination | - | 49.31 | 21890473 | |
| 98 | Ubiquitination | DELKDWIKFAQKRWI HHHHHHHHHHHHHHC | 30.32 | 983 | |
| 98 | Acetylation | DELKDWIKFAQKRWI HHHHHHHHHHHHHHC | 30.32 | 27452117 | |
| 102 | Ubiquitination | DWIKFAQKRWIYEDV HHHHHHHHHHCHHCH | 46.39 | - | |
| 102 | Ubiquitination | DWIKFAQKRWIYEDV HHHHHHHHHHCHHCH | 46.39 | 21890473 | |
| 106 | Phosphorylation | FAQKRWIYEDVERQW HHHHHHCHHCHHHHH | 10.10 | 25884760 | |
| 106 | Ubiquitination | FAQKRWIYEDVERQW HHHHHHCHHCHHHHH | 10.10 | 21890473 | |
| 111 | Methylation | WIYEDVERQWKGHDL HCHHCHHHHHCCCCC | 47.73 | - | |
| 114 | Ubiquitination | EDVERQWKGHDLNED HCHHHHHCCCCCCCC | 37.72 | 21890473 | |
| 122 | Ubiquitination | GHDLNEDGLVSWEEY CCCCCCCCCCCHHHH | 23.07 | 21890473 | |
| 125 | Phosphorylation | LNEDGLVSWEEYKNA CCCCCCCCHHHHCCC | 33.54 | 25159151 | |
| 129 | Phosphorylation | GLVSWEEYKNATYGY CCCCHHHHCCCCEEE | 9.68 | - | |
| 130 | Ubiquitination | LVSWEEYKNATYGYV CCCHHHHCCCCEEEE | 43.30 | - | |
| 131 | N-linked_Glycosylation | VSWEEYKNATYGYVL CCHHHHCCCCEEEEC | 36.29 | 19139490 | |
| 150 | Ubiquitination | PDDGFNYKQMMVRDE CCCCCCHHHEEHHCH | 32.59 | - | |
| 150 (in isoform 2) | Ubiquitination | - | 32.59 | - | |
| 162 | Sulfoxidation | RDERRFKMADKDGDL HCHHHHCCCCCCCCE | 5.54 | 21406390 | |
| 165 | Acetylation | RRFKMADKDGDLIAT HHHCCCCCCCCEEEE | 54.81 | 26051181 | |
| 165 | Ubiquitination | RRFKMADKDGDLIAT HHHCCCCCCCCEEEE | 54.81 | - | |
| 172 | Phosphorylation | KDGDLIATKEEFTAF CCCCEEEEHHHHHHH | 31.81 | 29083192 | |
| 173 | Ubiquitination | DGDLIATKEEFTAFL CCCEEEEHHHHHHHC | 46.34 | - | |
| 177 | Phosphorylation | IATKEEFTAFLHPEE EEEHHHHHHHCCHHH | 21.56 | 29083192 | |
| 185 | Phosphorylation | AFLHPEEYDYMKDIV HHCCHHHHHHHHHHH | 15.65 | 29083192 | |
| 187 | Phosphorylation | LHPEEYDYMKDIVVQ CCHHHHHHHHHHHHH | 12.74 | - | |
| 188 | Sulfoxidation | HPEEYDYMKDIVVQE CHHHHHHHHHHHHHH | 2.62 | 30846556 | |
| 196 | Phosphorylation | KDIVVQETMEDIDKN HHHHHHHHHHHHHHC | 14.58 | 23663014 | |
| 197 | Sulfoxidation | DIVVQETMEDIDKNA HHHHHHHHHHHHHCC | 4.24 | 28465586 | |
| 213 (in isoform 10) | Phosphorylation | - | 10.79 | 23663014 | |
| 217 | Sulfoxidation | LEEYIGDMYSHDGNT HHHHHHHHCCCCCCC | 2.89 | 30846556 | |
| 219 (in isoform 10) | Phosphorylation | - | 14.41 | 23663014 | |
| 224 | Phosphorylation | MYSHDGNTDEPEWVK HCCCCCCCCCCHHHH | 47.47 | - | |
| 224 | O-linked_Glycosylation | MYSHDGNTDEPEWVK HCCCCCCCCCCHHHH | 47.47 | OGP | |
| 248 | Methylation | RDKNRDGKMDKEETK HHCCCCCCCCHHHHC | 48.49 | - | |
| 249 | Sulfoxidation | DKNRDGKMDKEETKD HCCCCCCCCHHHHCC | 12.45 | 30846556 | |
| 254 | Phosphorylation | GKMDKEETKDWILPS CCCCHHHHCCCCCCC | 35.08 | 23917254 | |
| 255 | Ubiquitination | KMDKEETKDWILPSD CCCHHHHCCCCCCCC | 55.11 | 2189047 | |
| 255 | Acetylation | KMDKEETKDWILPSD CCCHHHHCCCCCCCC | 55.11 | 26051181 | |
| 255 (in isoform 2) | Ubiquitination | - | 55.11 | 21890473 | |
| 261 | Phosphorylation | TKDWILPSDYDHAEA HCCCCCCCCCCHHHH | 45.41 | 20873877 | |
| 261 | O-linked_Glycosylation | TKDWILPSDYDHAEA HCCCCCCCCCCHHHH | 45.41 | 62171197 | |
| 263 | Phosphorylation | DWILPSDYDHAEAEA CCCCCCCCCHHHHHH | 17.61 | 23186163 | |
| 263 | Ubiquitination | DWILPSDYDHAEAEA CCCCCCCCCHHHHHH | 17.61 | 21890473 | |
| 275 | Phosphorylation | AEARHLVYESDQNKD HHHHHHHHHCCCCCC | 18.97 | 25884760 | |
| 275 | Nitration | AEARHLVYESDQNKD HHHHHHHHHCCCCCC | 18.97 | - | |
| 277 | Phosphorylation | ARHLVYESDQNKDGK HHHHHHHCCCCCCCC | 27.15 | 28152594 | |
| 281 | Ubiquitination | VYESDQNKDGKLTKE HHHCCCCCCCCCCHH | 63.32 | - | |
| 287 | Sumoylation | NKDGKLTKEEIVDKY CCCCCCCHHHHHHHH | 64.88 | - | |
| 287 | Sumoylation | NKDGKLTKEEIVDKY CCCCCCCHHHHHHHH | 64.88 | - | |
| 287 | Ubiquitination | NKDGKLTKEEIVDKY CCCCCCCHHHHHHHH | 64.88 | - | |
| 293 | Ubiquitination | TKEEIVDKYDLFVGS CHHHHHHHHCEEEEC | 29.75 | - | |
| 300 | Phosphorylation | KYDLFVGSQATDFGE HHCEEEECCCCCHHH | 16.02 | 23663014 | |
| 300 | O-linked_Glycosylation | KYDLFVGSQATDFGE HHCEEEECCCCCHHH | 16.02 | OGP | |
| 303 | Phosphorylation | LFVGSQATDFGEALV EEEECCCCCHHHHHH | 24.99 | 23663014 | |
| 303 | O-linked_Glycosylation | LFVGSQATDFGEALV EEEECCCCCHHHHHH | 24.99 | OGP |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 44 | S | Phosphorylation | Kinase | PLK2 | Q9NYY3 | PSP |
| 44 | S | Phosphorylation | Kinase | PLK3 | Q9H4B4 | PSP |
| 60 | T | Phosphorylation | Kinase | PLK2 | Q9NYY3 | PSP |
| 60 | T | Phosphorylation | Kinase | PLK3 | Q9H4B4 | PSP |
| 69 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| 73 | T | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
| 177 | T | Phosphorylation | Kinase | PLK3 | Q9H4B4 | PSP |
| 196 | T | Phosphorylation | Kinase | PLK2 | Q9NYY3 | PSP |
| 196 | T | Phosphorylation | Kinase | PLK3 | Q9H4B4 | PSP |
| 254 | T | Phosphorylation | Kinase | PLK3 | Q9H4B4 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CALU_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CALU_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-131, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND THR-65, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-65, AND MASSSPECTROMETRY. | |